Clinical Significance and Effect of MTDH/AEG-I in Bladder Urothelial Cancer: A Study Based on Immunohistochemistry, RNA-Seq, and in vitro Verification [Retraction]
Zhang Y, Zhang L-J, Dang Y-W, Li S-H, Yan H-B, Chen G. Clinical significance and effect of MTDH/AEG-I in bladder urothelial cancer: a study based on immunohistochemistry, RNA-seq, and in vitro verification. Cancer Manag Res. 2018;10:6921– 6936.
At the request of the authors, the Editor-in-Chief and Publisher of Cancer Management and Research wish to
retract the published article.
Following a review of their experimental data the authors found they had inadvertently duplicated the Hoechst 33342 and propidium iodide (PI) images presented in Figure 11 of the published article, from Figure 11 of their liver cancer study:
The essential role of MTDH in the progression of HCC: a study with immunohistochemistry, TCGA, meta-analysis and in vitro investigation. He R, Gao L, Ma J, et al. Am J Transl Res 2017;9(4):1561– 1579. http://www.ajtr.org/files/ajtr0043681.pdf.
This retraction relates to this paper
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]